Roth Capital analyst Harry Fong lowered the firm’s price target on Marsh McLennan (MMC) to $200 from $230 and keeps a Neutral rating on the shares. Marsh McLennan’s Q3 underlying revenue growth was up 4%, which was likely below expectations, but in line with the firm’s estimate, though the composition was different than the firm expected, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC:
- Marsh McLennan upgraded to Neutral from Sell at Goldman Sachs
- BMO cuts Marsh McLennan price target, says shares ‘potentially not inexpensive’
- Marsh McLennan price target lowered to $195 from $215 at Morgan Stanley
- Marsh McLennan price target lowered to $237 from $243 at Evercore ISI
- Marsh & McLennan Companies: Hold Rating Reaffirmed Amid Operational Challenges and Macroeconomic Uncertainties
